Viviane Dias Lima
Viviane Dias Lima
BC Centre for Excellence in HIV/AIDS & University of British Columbia
Verified email at
Cited by
Cited by
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
Antiretroviral Therapy Cohort Collaboration
The Lancet 372 (9635), 293-299, 2008
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
JSG Montaner, VD Lima, R Barrios, B Yip, E Wood, T Kerr, K Shannon, ...
The Lancet 376 (9740), 532-539, 2010
Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale‐up in the age of direct‐acting antivirals
NK Martin, P Vickerman, J Grebely, M Hellard, SJ Hutchinson, VD Lima, ...
Hepatology 58 (5), 1598-1609, 2013
Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada
W Zhang, N O’Brien, JI Forrest, KA Salters, TL Patterson, JSG Montaner, ...
PloS one 7 (7), e40793, 2012
Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV Treatment as Prevention” experience in aá…
JSG Montaner, VD Lima, PR Harrigan, L Lourenšo, B Yip, B Nosyk, ...
PloS one 9 (2), e87872, 2014
The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time
VD Lima, R Harrigan, DR Bangsberg, RS Hogg, R Gross, B Yip, ...
Journal of acquired immune deficiency syndromes (1999) 50 (5), 529, 2009
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy
VD Lima, RS Hogg, PR Harrigan, D Moore, B Yip, E Wood, JSG Montaner
Aids 21 (6), 685-692, 2007
Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review andá…
RK Gupta, A Hill, AW Sawyer, A Cozzi-Lepri, V von Wyl, S Yerly, VD Lima, ...
The Lancet infectious diseases 9 (7), 409-417, 2009
The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART
VD Lima, J Geller, DR Bangsberg, TL Patterson, M Daniel, T Kerr, ...
Aids 21 (9), 1175-1183, 2007
Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic
VD Lima, K Johnston, RS Hogg, AR Levy, PR Harrigan, A Anema, ...
The Journal of infectious diseases 198 (1), 59-67, 2008
The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study
B Nosyk, JSG Montaner, G Colley, VD Lima, K Chan, K Heath, B Yip, ...
The Lancet infectious diseases 14 (1), 40-49, 2014
The association between food insecurity and mortality among HIV-infected individuals on HAART
SD Weiser, KA Fernandes, EK Brandson, VD Lima, A Anema, ...
Journal of acquired immune deficiency syndromes (1999) 52 (3), 342, 2009
Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART
RS Hogg, DR Bangsberg, VD Lima, C Alexander, S Bonner, B Yip, ...
PLoS medicine 3 (9), e356, 2006
Highly active antiretroviral therapy and survival in HIV-infected injection drug users
E Wood, RS Hogg, VD Lima, T Kerr, B Yip, BDL Marshall, JSG Montaner
Jama 300 (5), 550-554, 2008
Differential impact of adherence on long-term treatment response among naive HIV-infected individuals
VD Lima, R Harrigan, M Murray, DM Moore, E Wood, RS Hogg, ...
Aids 22 (17), 2371-2380, 2008
N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance
SH Yap, CW Sheen, J Fahey, M Zanin, D Tyssen, VD Lima, B Wynhoven, ...
PLoS Medicine 4 (12), e335, 2007
Risk of viral failure declines with duration of suppression on HAART, irrespective of adherence level
VD Lima, DR Bangsberg, PR Harrigan, SG Deeks, B Yip, RS Hogg, ...
Journal of acquired immune deficiency syndromes (1999) 55 (4), 460, 2010
Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection
VS Gill, VD Lima, W Zhang, B Wynhoven, B Yip, RS Hogg, JSG Montaner, ...
Clinical infectious diseases 50 (1), 98-105, 2010
The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users
S Nolan, V Dias Lima, N Fairbairn, T Kerr, J Montaner, J Grebely, E Wood
Addiction 109 (12), 2053-2059, 2014
Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
S Patterson, A Cescon, H Samji, K Chan, W Zhang, J Raboud, ...
BMC infectious diseases 15 (1), 1-10, 2015
The system can't perform the operation now. Try again later.
Articles 1–20